1 are cytochrome P450-like hemoprotein enzymes that catalyze the conversion of L-arginine to citrulline and nitric oxide (1-4). Nitric oxide is a signaling molecule that is involved in a variety of physiological processes, including neurotransmission, vasorelaxation, platelet aggregation, and penile erection as well as in a variety of pathological conditions including septic shock, reperfusion injury, arthritis, atherosclerosis, diabetes, and graft rejection (5-8). It has been noted (9) that because nitric oxide is not stored, released, or inactivated after synaptic release by conventional regulatory mechanisms the biosynthetic regulation of the enzyme is of great importance. For the neuronal isoform the Ca 2ϩ -mediated activation is of prime importance. However, the factors that regulate proteolytic degradation of the enzyme have not been investigated. One approach that has been successfully utilized for the study of the proteolytic turnover of other P450 cytochromes is the use of suicide inactivators (10 -13). We wished to utilize this approach for the study of NOS turnover.
including neurotransmission, vasorelaxation, platelet aggregation, and penile erection as well as in a variety of pathological conditions including septic shock, reperfusion injury, arthritis, atherosclerosis, diabetes, and graft rejection (5) (6) (7) (8) . It has been noted (9) that because nitric oxide is not stored, released, or inactivated after synaptic release by conventional regulatory mechanisms the biosynthetic regulation of the enzyme is of great importance. For the neuronal isoform the Ca 2ϩ -mediated activation is of prime importance. However, the factors that regulate proteolytic degradation of the enzyme have not been investigated. One approach that has been successfully utilized for the study of the proteolytic turnover of other P450 cytochromes is the use of suicide inactivators (10 -13) . We wished to utilize this approach for the study of NOS turnover.
Suicide inactivators are chemically inert molecules that mimic the natural substrate of the enzyme and become metabolized to a highly reactive intermediate that can covalently alter important active site entities, resulting in inactivation of the enzyme (14) . In effect, the compound causes the enzyme to catalyze its own demise. Because the compound must not only have affinity for the active site but also must be metabolized in a manner to generate a reactive intermediate that is in close proximity to an important active site entity, these agents have the potential to be highly specific in vivo. In addition, they react with the form of the enzyme that is engaged in catalysis and thus are useful mechanistic probes into the nature of the bioactivation reaction. In some cases, these agents covalently alter P450 cytochromes in a manner that enhances their proteolysis and turnover (10 -13, 15-17) .
Guanabenz, a clinically used antihypertensive agent with a guanidino moiety, was recently shown, with the use of brain and penile cytosol, to be a metabolism-based inactivator of neuronal nitric-oxide synthase (nNOS) (18) . Moreover, the treatment of rats with guanabenz was found to cause not only a decrease in activity, but also a concomitant loss of immunodetectable nNOS protein. To further understand the molecular mechanisms responsible for the loss of nNOS protein in vivo, we chose to model the effects of guanabenz with the use of HEK 293 cells stably transfected with nNOS. In the current study, we have shown that guanabenz causes the enhanced proteolytic turnover of nNOS. Suicide inactivators of nNOS, such as N G -methyl-L-arginine or N 5 -(1-iminoethyl)-L-ornithine, also caused the enhanced proteolytic degradation of the enzyme, whereas the slowly reversible inhibitor N G -nitro-L-arginine or the reversible inhibitor 7-NI did not. Studies with protease inhibitors indicate that the proteasome is responsible, in part, for recognition of the inactivated protein. Thus, the steady state levels of nNOS may be regulated by a selective proteolytic process, which can be studied by the use of metabolism-based inactivators. 
EXPERIMENTAL PROCEDURES

Materials
The affinity-purified rabbit IgG against brain NOS used for immunoblotting nNOS was from Transduction Laboratories (Lexington, KY). The rabbit antiserum used to immunoprecipitate nNOS was raised against rat neuronal NOS and was the generous gift of Dr. Lance Pohl (NHLBI, Bethesda, MD). The antibody was affinity purified prior to use. Lactacystin, 7-NI, N 5 -(1-iminoethyl)-L-ornithine, and Cbz-leucineleucine-leucinal (MG132) were purchased from BIOMOL (Plymouth Meeting, PA). Guanabenz was purchased from Research Biochemicals International (Natick, MA). (3) . Seventeen hours before harvesting, the cells were cultured in DMEM containing 0.1 mM arginine (low arginine DMEM). HEK cells were harvested, washed with ice-cold phosphatebuffered saline, and homogenized with a Tenbroeck ground glass homogenizer in 2 volumes of HS buffer (10 mM Hepes, pH 7.5, 0.32 M sucrose, 0.1 mM EDTA, 1.5 mM dithiothreitol, 10 g/ml trypsin inhibitor, 10 g/ml leupeptin, 2 g/ml aprotinin, 0.1 mM tetrahydrobiopterin, and 1.0 mg/ml phenylmethylsulfonyl fluoride). Homogenates were centrifuged for 60 min at 100,000 ϫ g with the supernatant being the cytosol fraction. The cytosolic fraction was loaded onto a Sephadex G-25 M column (PD-10, Amersham Pharmacia Biotech) preequilibrated in HS buffer without tetrahydrobiopterin to remove endogenous arginine and excess tetrahydrobiopterin as described previously (18) . The cytosolic fraction was stored at Ϫ80°C until use.
NOS Activity Assay-For studies on the time-dependent irreversible inactivation of nNOS, 30 -50 l of HEK cytosol was added to a mixture of 40 mM potassium phosphate, pH 7.4, containing 1.0 mM NADPH, 0.2 mM CaCl 2 , 500 unit/ml superoxide dismutase, 100 unit/ml catalase, 10 g/ml calmodulin, and guanabenz at various concentrations in a total volume of 150 l at room temperature. Aliquots (20 l) of the reaction mixture were transferred to an oxyhemoglobin oxidation assay mixture containing 200 M CaCl 2 , 100 M NADPH, 100 M L-arginine, 100 M tetrahydrobiopterin, 100 units/ml catalase, 10 g/ml calmodulin, and 8 M oxyhemoglobin in a total volume of 200 l of 50 mM potassium phosphate, pH 7.4. The mixture was incubated at 37°C, and the rate of nitric oxide-mediated oxidation of oxyhemoglobin was monitored by measuring the absorbance at 401-411 nm with a microtiter plate reader (SpectraMax Plus, Molecular Devices, Sunnydale, CA) as described previously (20) .
For studies on the short term inhibition of nNOS caused by guanabenz, 8 g of HEK 293 cytosolic protein was added to an assay mixture containing 1 mM CaCl 2 , 1 mM NADPH, 100 M tetrahydrobiopterin, 10 g/ml calmodulin, and radiolabeled arginine (320 mCi/mmol, 5.0 M) in a total volume of 50 l of 40 mM potassium phosphate, pH 7.4. After incubation at 37°C for 3 min, the conversion of arginine to citrulline was determined by ion exchange purification as described previously (18) . The K m determined for arginine by this method was 4.4 M, which is consistent with that found by other laboratories (21, 22) .
The oxyhemoglobin assay was monitored over time to ensure linearity of the assay, typically over a 4-min period. The activity was also linear with respect to protein up to 25 l of HEK cytosol. The 14 Clabeled arginine assay was linear up to 18 g of HEK protein and over the initial 3 min of incubation. In both cases the plot of activity versus protein gave a line (r 2 Ͼ 0.98) that intersects the origin. The assays were performed in the linear range of protein and time in all cases.
Nitrite and Nitrate Assay-Aliquots of medium (200 l) from flasks (75 cm 2 ) containing HEK 293 cells were taken for assay of nitrite and nitrate as described (23) . Nitrate reductase (Roche Molecular Biochemicals) was used to convert the nitrate to nitrite, which was quantified by the use of the Griess reagent. Sodium nitrate in culture medium was used as a standard.
SDS-Polyacrylamide Gel Electrophoresis and Western
Blotting-HEK 293 cells stably transfected with nNOS were cultured in 24-well plates (5 ϫ 10 4 cells/well) in low arginine DMEM. After 40 h, the medium was aspirated, and 1 ml of low arginine DMEM was added. The cells were treated with cycloheximide (40 M), guanabenz (100 M), or guanabenz (100 M) and cycloheximide (40 M) for 24 h. The cells were harvested, washed with phosphate-buffered saline, counted, and collected by centrifugation. The cells were lysed with 45 l of Nonidet P-40 lysis buffer (1% Nonidet P-40, 150 mM NaCl, 3 mM phenylmethylsulfonyl fluoride, 0.1 mM leupeptin, 0.5 mM pepstatin, 2 g/ml aprotinin in 50 mM Tris-Cl, pH 8) and centrifuged at 16,000 ϫ g for 10 min at 4°C. The supernatant was taken as cell lysates and the protein concentration measured by Micro BCA assay (Pierce) using bovine serum albumin as a standard. Samples (1 g) were subjected to electrophoresis on 7% SDS-polyacrylamide gels (10 ϫ 8 cm) with the use of the discontinuous buffer system described by Laemmli (24) , and transferred to nitrocellulose membranes (0.2 m, Bio-Rad). The membranes were probed with an anti-nNOS polyclonal antibody (1:1000, Transduction Laboratories). An anti-rabbit IgG conjugated to peroxidase (1:10,000, Roche Molecular Biochemicals) was used as a secondary antibody. The bands were visualized by the use of ECL reagent (Super Signal, Pierce) and X-OMAT film (Eastman Kodak Co.) as described by the manufacturer. The intensity of the signals was quantified by laser densitometry (GS-670, Bio-Rad). In some experiments, N G -methyl-L-arginine or N Gnitro-L-arginine was used in place of guanabenz.
Metabolic Labeling and Immunoprecipitation-HEK 293 cells stably transfected with nNOS were cultured in 6-well plates (2.5 ϫ 10 5 cells/ well) in low arginine DMEM. Cells were incubated with 1.0 ml of methionine-free medium for 60 min, and then 80 Ci of [
35 S]methionine (NEN Life Science Products, Expre 35 S 35 S Protein labeling mix) was added. Following the labeling period, the medium was changed to 5.0 ml of low arginine DMEM containing 1 mM methionine. At appropriate time intervals, the chase was terminated by solubilization with 100 l of ice-cold Nonidet P-40 lysis buffer. Cell debris was removed by centrifugation at 16,000 ϫ g in a microfuge for 10 min. nNOS was immunoadsorbed from the cell lysates with 15 l of anti-nNOS IgG and 2.0 mg of protein A-Sepharose (25) . Immune pellets were washed three times with Nonidet P-40 lysis buffer and bound antigen was eluted from the beads by boiling in SDS sample buffer with dithiothreitol (6.0 mg/ml). The purified proteins were resolved on 7% SDS-polyacrylamide gels as described above. The radioactivity was quantified with the use of a PhosphorImager (Model 445 SI, Molecular Dynamics). The addition of excess arginine, tetrahydrobiopterin, calmodulin, FMN, and FAD did not restore activity (data not shown). The kinetics are highly similar to that established for the native enzyme found in cytosolic fractions prepared from rat brain or penile tissue (18) and are consistent with a suicide mechanism whereby a substrate is metabolized to a reactive intermediate that covalently alters nNOS and inactivates the enzyme (14) . As shown in Fig. 1D , when nNOS was co-incubated with guanabenz and arginine for a short period (3 min), to minimize the time-dependent effects, nNOS was inhibited by guanabenz in a concentration-dependent manner. These effects were relatively small in that 100 M guanabenz caused approximately 25% inhibition.
RESULTS
Effect of Guanabenz on Neuronal NOS Activity in Cytosol
Guanabenz Decreases nNOS Activity in Transfected HEK
293 Cells-Treatment of transfected HEK 293 cells with the calcium ionophore, A23187, leads to the rapid and time-dependent accumulation of nitrite and nitrate, which are stable oxidation products of NO, in the culture medium (Fig. 2) . This is expected because nNOS is a Ca 2ϩ /calmodulin-regulated enzyme. Pre-treatment of HEK 293 cells for 10 min with guanabenz caused a concentration-dependent decrease in the amount of accumulated nitrite and nitrate, indicating the loss of nNOS activity (Fig. 2) . For example, within the first 3 h of treatment, 50 M guanabenz decreased the accumulation of nitrite and nitrate by approximately 75% (cf. open squares with closed squares).
Effect of Guanabenz and Other Inhibitors on nNOS Activity in Transfected HEK 293 Cells-The activity of nNOS was determined after treatment of intact cells with the irreversible inhibitors guanabenz, N
5 -(1-iminoethyl)-L-ornithine (NIO), and NMA as well as the reversible inhibitor 7-NI in the presence of calcium ionophore (Fig. 3) . In these studies the cells were treated with inhibitors, washed, and harvested, and the nNOS activity of the cell homogenates was measured by the oxyhemoglobin method. Although all compounds decreased cellular nitrite/nitrate production (data not shown), there is no apparent inhibition due to the reversible inhibitor 7-NI due to the washing step and subsequent dilution of the cell extract into the arginine containing oxyhemoglobin assay mixture. We found that guanabenz, NIO, and NMA caused a decrease in nNOS activity after 1 h of treatment over that found for 7-NI, indicating that irreversible inactivation had occurred. The cells treated with ionophore alone (A23187) have a decreased nNOS activity over that found for 7-NI-treated cells, perhaps due to the effects of nitric oxide or oxidants that are generated (26) . (Fig. 4) . A similar decrease was observed when translation of new enzyme was blocked with cycloheximide (CX). Consistent with a guanabenz-mediated increase in nNOS turnover, guanabenz in the presence of cycloheximide (G ϩ CX) caused an approximately 80% decrease of immunodetectable nNOS. This effect was not unique to guanabenz as N G -methyl-L-arginine, which suicide inactivates nNOS (27, 28) , caused an approximately 80% decrease in immunodetectable nNOS in the presence of cycloheximide (NMA ϩ CX). This effect was selective as N G -nitro-L-arginine (NNA), a slowly reversible inhibitor of nNOS (29) , in the presence of cycloheximide (NNA ϩ CX) did not cause a decrease of immunodetectable nNOS over that found for CX alone. Because the 24-h treatment with guanabenz was required to decrease nNOS protein by 35% (Fig. 4) , the 75% decrease in nNOS activity observed within 3 h of treatment cannot be due to enhanced degradation alone, but was most likely due to inactivation of the enzyme.
Effect of Guanabenz and Other Inactivators on the Degradation of nNOS in Transfected HEK 293 Cells-Treatment of HEK 293 cells for 24 h with guanabenz (G) caused an approximately 35% decrease in the amount of immunodetectable nNOS protein
To further verify that the inactivators were enhancing the proteolysis of nNOS, we undertook pulse-chase studies with SDS-polyacrylamide gel electrophoresis revealed that nNOS could be selectively measured and that treatment with guanabenz during the chase resulted in a lower amount of radiolabeled nNOS over time in comparison to the controls (Fig. 5A) . The radioactivity associated with nNOS was quantified by the use of a PhosphorImager and plotted against the duration of the chase (Fig. 5B) . The loss of radioactive nNOS appeared to be monophasic and first-order with a half-life of approximately 20 h (open circles). Guanabenz caused the half-life of nNOS to decrease to approximately 10 h (closed squares).
To determine the effect of other inhibitors and inactivators on nNOS degradation, we determined the amount of radioactive nNOS present after 20 h of chase (Fig. 6) . As expected, 100 M guanabenz caused a 50% decrease in radiolabeled nNOS in comparison to the control (cf. G with Con). At a concentration of 100 M, NMA and NIO caused a similar decrease of approximately one-half in the amount of radiolabeled nNOS. The slowly reversible inhibitor, NNA, and the reversible inhibitor, 7-nitroindazole (7NI), had no effect on the amount of radiolabeled nNOS in comparison to the control (Con).
Effect of Protease Inhibitors on the Degradation of nNOS in HEK 293
Cells-The degradation of nNOS that occurs in the presence of 100 M guanabenz was further characterized with the use of protease inhibitors. Treatment of cells with 10 M lactacystin, 100 M N-acetyl-leucine-leucine-norleucinal (ALLN), or 10 M Cbz-leucine-leucine-leucinal (MG132) were found to completely protect nNOS from degradation (Fig. 7) . Similar protective effects were seen in cells that were not treated with guanabenz (data not shown). All these agents have been shown to inhibit the proteasome, although the peptidic aldehydes ALLN and MG132 can inhibit other proteases including lysosomal proteases, calpain, and cathepsins (30) . Lactacystin, on the other hand, appears to be highly selective for the proteasome (31, 32) . Leupeptin, an inhibitor of lysosomal cysteine proteases, was not effective in preventing the degradation of nNOS.
DISCUSSION
Administration of guanabenz to rats was previously shown to cause the loss of immunodetectable nNOS protein from penile tissue (18) . Consistent with these observations, we show here that the treatment of intact HEK 293 cells with guanabenz caused a decrease in cellular nNOS activity as well as a decrease in the level of immunodetectable nNOS. 35 S]methionine, and the rate of degradation of the nNOS was determined as described under "Methods." The cells were treated with guanabenz (100 M) at the start of the chase. A, the gel was exposed to x-ray film for visualization of the immunoprecipitated nNOS. B, the radioactivity was quantified by the use of a PhosphorImager as described under "Methods." The values are the mean Ϯ S.E. of three samples. the reversible inhibitor 7-NI did not have an effect on the turnover of the protein. These results are entirely consistent with the lack of effect on the level of immunodetectable nNOS observed after treatment of rats with L-NNA even though there is inhibition of the enzyme (18) . Thus, the enhanced degradation of nNOS is not due to inhibition of the activity alone, but is likely due to some selective action on the enzyme by the suicide inactivators.
Although this is the first report of inactivator-mediated enhanced turnover for nNOS, the enhanced degradation of suicide inactivated liver microsomal cytochrome P450 enzymes, which are similar to NOS, has been described (11) (12) (13) 16) . Correia et al. (10) have shown that administration of the suicide inactivator 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine to rats lead to inactivation and loss of immunochemically detectable cytochrome P450 3A from the endoplasmic reticulum. Noguchi et al. (15) observed that treatment of rats with the suicide inactivator CCl 4 caused the selective loss of a protein, which was thought to be a cytochrome P450. More recently, Koop and co-workers (11) have definitively shown that administration of CCl 4 to rats leads to inactivation and loss of cytochrome P450 2E1. In accord with our current findings, it appears that structural changes and not the functional inactivation per se appear to be the "trigger" for proteolysis (10, 11) . Interestingly, both 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine and CCl 4 are known to cause the covalent alteration of the heme to protein-bound adducts (33) . Moreover, it appears that the protein-bound heme adducts play a major role in proteolytic recognition because the inactivation of cytochrome P450 2E1 with 1-aminobenzotriazole, which leads to N-alkylation of the heme (11), "heme stripping" of cytochrome P450 3A after treatment with allylisopropylacetamide (12, 34) , which leads to the formation of apoprotein, and secobarbital-mediated inactivation of cytochrome P450 2B1 (35) , which leads to direct covalent alteration of the protein, all fail to enhance the proteolysis of the affected P450 cytochromes. Thus, in accord with the above precedents, it is possible that nNOS is covalently altered, perhaps at the heme prosthetic group, and is subsequently recognized by proteases. In this respect, L-NMA has been shown to modify the heme prosthetic group of NOS during suicide inactivation (36) .
The enhanced degradation of the inducible isoform of nitricoxide synthase has been described (37) . The mechanism of suppression of inducible NOS by dexamethasone in ␥-interferon treated RAW 264.7 cells is due in part to the enhanced turnover of the protein as well as effects on transcription and translation (37) . Based on the effects of ALLN, the protease responsible for the enhanced degradation of inducible NOS was identified as calpain. Calpain also appears to be responsible for the proteolytic degradation of nNOS in neurotoxin-treated cortical cells (38) as well as in in vitro systems (39) . Our studies with the use of lactacystin strongly suggest that the proteasome is the major protease responsible for degradation of nNOS in our cellular system. In this respect, the proteasome has also been implicated in the degradation of suicide inactivated liver P450 cytochromes (16, 17) .
The current studies describe for the first time that inactivators of nNOS cause the enhanced degradation of the enzyme, which may explain in part the effects seen on nNOS after administration of guanabenz to rats. Moreover, we implicate the proteasome as the major protease responsible for the enhanced degradation of nNOS. The current studies provide important tools for the study of the mechanism responsible for the enhanced turnover of the protein that may be important in the design and evaluation of inactivators of nNOS. In this respect, the model system developed here may provide a method to screen compounds for the inactivation and degradation of nNOS that may occur in vivo.
